| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Analysis of docetaxel pharmacokinetics in humans with the inclusion of later sampling time-points afforded by the use of a sensitive tandem LCMS assay
|
Gustafson, Daniel L.
|
|
2003
|
52 |
2 |
p. 159-166
|
artikel
|
| 2 |
A phase I trial of weekly paclitaxel, 13-cis-retinoic acid, and interferon alpha in patients with prostate cancer and other advanced malignancies
|
Thalasila, A.
|
|
2003
|
52 |
2 |
p. 119-124
|
artikel
|
| 3 |
A retrospective evaluation of the feasibility of intrapatient dose escalation as appropriate methodology for dose-ranging studies for combination cytotoxic regimens
|
Jordan, Sarah D.
|
|
2003
|
52 |
2 |
p. 113-118
|
artikel
|
| 4 |
Biliary excretion of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) and metabolites by Fischer 344 rats
|
Musser, Steven M.
|
|
2003
|
52 |
2 |
p. 139-146
|
artikel
|
| 5 |
Effective combination of ET-743 and doxorubicin in sarcoma: preclinical studies
|
Meco, Daniela
|
|
2003
|
52 |
2 |
p. 131-138
|
artikel
|
| 6 |
Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics
|
Lima Vazquez, Vinicius de
|
|
2003
|
52 |
2 |
p. 108-112
|
artikel
|
| 7 |
Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study
|
Donadio, Michela
|
|
2003
|
52 |
2 |
p. 147-152
|
artikel
|
| 8 |
Granisetron: is there a dose–response effect on nausea and vomiting?
|
Minami, Masaru
|
|
2003
|
52 |
2 |
p. 89-98
|
artikel
|
| 9 |
Metabolism of dexrazoxane (ICRF-187) used as a rescue agent in cancer patients treated with high-dose etoposide
|
Schroeder, Patricia E.
|
|
2003
|
52 |
2 |
p. 167-174
|
artikel
|
| 10 |
Modelling of ftorafur and 5-fluorouracil pharmacokinetics following oral UFT administration. A population study in 30 patients with advanced breast cancer
|
Urien, S.
|
|
2003
|
52 |
2 |
p. 99-107
|
artikel
|
| 11 |
Phase II study of biweekly irinotecan and mitomycin C combination therapy in patients with fluoropyrimidine-resistant advanced colorectal cancer
|
Yamada, Yasuhide
|
|
2003
|
52 |
2 |
p. 125-130
|
artikel
|
| 12 |
Phase I trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: a Cancer Therapeutics Research Group study
|
Soo, Ross A.
|
|
2003
|
52 |
2 |
p. 153-158
|
artikel
|
Tijdschrift beschrijving